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Approximate Entropy Values Demonstrate Impaired Neuromotor Control of Spontaneous Leg 2 
Activity in Infants with Myelomeningocele 3 
ABSTRACT 4 
 Purpose: One obstacle to providing early intervention to infants with myelomeningocele 5 
(MMC) is the challenge of quantifying impaired neuromotor control of movements early in life. 6 
Methods: We used the nonlinear analysis tool Approximate Entropy (ApEn) to analyze 7 
periodicity and complexity of supine spontaneous lower extremity movements of infants with 8 
MMC and typical development (TD) at 1, 3, 6 and 9 months of age. Results: Movements of 9 
infants with MMC were more regular and repeatable (lower ApEn values) than movements of 10 
infants with TD indicating less adaptive and flexible movement patterns. For both groups ApEn 11 
values decreased with age, and the movements of infants with MMC were less complex than 12 
movements of infants with TD. Further, for infants with MMC, lesion level and age of walking 13 
onset correlated negatively with ApEn values. Conclusions: Our study begins to demonstrate the 14 
feasibility of ApEn to identify impaired neuromotor control in infants with MMC. 15 
 2 
INTRODUCTION AND PURPOSE 1 
 Myelomeningocele (MMC) is the most common neural tube defect in the United States, 2 
affecting 1,500 to 2,000 infants born each year 1. A primary effect of MMC is impaired sensori-3 
motor function of the lower extremities, negatively influencing the ability to walk. The 4 
likelihood that children with MMC will walk ranges from approximately 20% for high lumbar 5 
lesions to 80% to 90% for sacral lesions, with a mean onset at 3 years or older 2,3. Those who do 6 
walk tend to expend a high amount of energy on walking, and by late childhood many shift to 7 
wheelchairs for community ambulation 2-4.  8 
 Although wheelchair use to save energy for other tasks may be the optimal decision at the 9 
time, this solution does not represent the optimal outcome overall. Minimizing gait energy costs 10 
and maximizing gait function to allow for independent ambulation across the lifespan would be 11 
an ideal outcome. Although this ideal outcome is not universally feasible, recent advances in the 12 
study of neuroplasticity and neurorehabilitation suggest that better outcomes are possible. 13 
Known principles of experience-dependent neuroplasticity include “use it or lose it”, “use it and 14 
improve it”, “specificity”, “repetition, intensity, time, salience and age matter” 5. Based on these 15 
principles, we propose that early intervention starting at birth, as opposed to our observations 16 
here and previously of physical therapy intervention starting around 3, 6 or even 9 months of age 17 
6, is necessary to promote optimal sensori-motor development of the lower extremities and future 18 
walking ability in infants with MMC.  19 
 Admittedly, many obstacles exist to providing aggressive early intervention from birth on 20 
for infants with MMC. Multiple medical issues may limit the time available for or shift the 21 
priority away from therapy interventions concerning long-term goals; parents or caregivers may 22 
perceive infants with MMC as fragile; or limited therapist and family resources may make very 23 
 3 
early intervention difficult to accomplish. Our focus here is on yet another important obstacle: 1 
the challenge of quantifying impaired lower extremity function early in life and relating lower 2 
extremity control early in infancy to later functional ambulation outcomes.  3 
 The challenge of quantifying impaired lower extremity function early in life and relating it 4 
to later functional ambulation outcomes is multi-factorial. Many of the early motor milestones 5 
are based on head and upper extremity movements, and infants with MMC generally do not 6 
demonstrate difficulty with these types of movements. They do have difficulty with lower 7 
extremity movements, which are generally not documented until later in motor milestone 8 
progressions on such measures as the Bayley Scales of Infant Development7 or the Test of Infant 9 
Motor Performance8. Although therapists can use lesion level and assessment of muscle strength 10 
as one component of their clinical decision-making process, these assessments are at the body 11 
structure and function level of the World Health Organization International Classification of 12 
Functioning, Disability and Health (ICF) model9 and arguably more removed from the goal of 13 
walking than an ICF activity level measure would be. Although many reports show ambulation 14 
outcomes are highly related to neurological level, there is still much disparity in outcomes as 15 
defined by lesion groups 10,11 or muscle function12. Further, manual muscle testing is fairly 16 
subjective and unstable in children with MMC under 5 years of age13 and motor development 17 
preceding ambulation varies even among children with MMC who have similar muscle 18 
function14. There are many factors beyond lesion level that contribute to walking achievement in 19 
children with MMC12. Our argument here is that an objective activity level assessment will 20 
provide more accurate and specific information about impairments and change in infant lower 21 
extremity function than current body structure and function level assessments. Although it has 22 
been demonstrated at an activity level that infants with MMC spontaneously move their lower 23 
 4 
extremities less than infants with typical development (TD) 6,15, less movement quantity alone is 1 
not sufficient to justify or guide therapeutic intervention. 2 
 In addition to assessing quantity of movements, another possibility is to assess how the 3 
movement changes over time. Nonlinear methods of analysis assess qualitative aspects of 4 
movement by directly exploring how each point in a movement trajectory influences the next and 5 
how movement patterns emerge over time. By showing how the movement trajectory changes 6 
across time, nonlinear methods can provide insight into the neuromotor control of the movement. 7 
A specific nonlinear tool that can quantify dynamic movement patterns is Approximate Entropy 8 
(ApEn). ApEn analyzes the regularity and repeatability of a signal over time. Values at zero 9 
signify greatest regularity and absolute rigidity of movement patterns, while values near 2 10 
represent great irregularity and very noisy movement patterns. We define these two ends of the 11 
spectrum as movement patterns with low complexity, while mid-range values correspond to 12 
movements that are highly complex. Thus, complexity is equated with the most well-controlled 13 
and adaptive movement patterns16,17. 14 
 Here we follow the theoretical perspective that health and optimal sensorimotor function is 15 
associated with a state of maximum complexity 17-20. We test the hypothesis that spontaneous 16 
lower extremity movements of infants with MMC are less complex and less organized than 17 
movements of infants with TD, as indicated by lower ApEn values in infants with MMC. 18 
Identifying impaired neuromotor control of lower extremity movements in infants with MMC 19 
will provide support for early intervention to promote optimal sensori-motor development of the 20 
lower extremities and walking ability. Further, this tool may be used to assess change in 21 
underlying control due to development or specific interventions. 22 
METHOD 23 
 5 
 The infants whose data we present here were participants in two different studies of infant 1 
stepping in our laboratory, one longitudinal (Study 1) and one cross-sectional (Study 2). Each 2 
study included measurement of treadmill stepping responses as well as separate recording of 3 
supine spontaneous leg movements. Although the treadmill stepping protocols were different 4 
between the studies, the overall length of testing and the amount of activity the infants performed 5 
was similar.  6 
 For Study 1, infants with MMC and TD came into the laboratory at 1, 3, 6, 9 and 12 7 
months of age and again at walking onset. We used a 6-camera Vicon Peak Motus real-time 8 
system (Vicon Motion Systems, Centennial, CO) to collect reflective marker position data at 60 9 
Hz during treadmill stepping and spontaneous movement testing 6,21. For Study 2, only infants 10 
with MMC participated and were between the ages of 2-5 months or 7-10 months. We used 2 11 
synchronized digital camcorders filming at 60Hz to record reflective marker positions during 12 
treadmill stepping and spontaneous movement testing22. An additional 12 infants with TD were 13 
invited to participate to increase our sample size and match the ages of the infants with MMC in 14 
Study 2. We previously published data on the quantity of spontaneous movements for a subset of 15 
the infants from Study 1 6. Here we have expanded our sample to include additional, older 16 
infants, and use a nonlinear analysis of complexity of lower extremity spontaneous movements 17 
to look more closely at development of segmental control. 18 
Participants 19 
 Overall, we included the data points for 56 infants in our analyses. Infants were 1 month of 20 
age (MMC = 5, TD = 9), 3 months of age (MMC = 8, TD = 9), 6 months of age (MMC = 7, TD 21 
= 6) or 9 months of age (MMC = 6, TD = 6). The data were a mix of cross-sectional and 22 
longitudinal; about half of the infants were tested more than once as they reached the older age 23 
 6 
groups. Specifically, two infants with MMC were tested at all 4 time points, 3 were tested 3 1 
times, 3 were tested 2 times and 3 were tested once. Ten infants with TD were tested twice and 2 
10 were tested once. Infants with TD were without known cognitive, sensory or motor 3 
impairments. Infants with MMC had lesions (level of repair) at or caudal to L1, and were 4 
excluded if they had neuromotor abnormalities other than those associated with MMC (e.g. 5 
Arnold Chiari II, hydrocephalus) or if they had a gestational age at birth < 28 weeks. We 6 
recruited infants through fliers and MMC clinics in hospitals in southeastern Michigan and 7 
northeastern Ohio. Approval for the study was granted through the Institutional Review Board at 8 
the University of Michigan and parents provided written informed consent for their infants to 9 
participate in this study. Tables 1 and 2 contain participant characteristics. 10 
Data Collection 11 
 For all spontaneous movement testing, we removed clothing and diapers and attached 12 
reflective markers (8mm diameter) to the lateral surface of the greater trochanter, ventral surface 13 
of the patella and ventral surface of the third metatarsal. We placed infants supine on a towel-14 
covered firm surface. We held their legs extended and parallel for the initial 10 s of each trial, 15 
then released their legs for the duration of data collection. A spotter stood near the infants’ head 16 
and maintained a hand on each shoulder to prevent the infant from rolling or scooting. Infants 17 
remained in supine and moved their legs freely. During trials, parents and researchers maintained 18 
conversation but did not directly interact with the infant. For Study 1, bilateral lower extremity 19 
reflective marker data were collected for 2 2-minute trials and 1 1-minute trial. For Study 2, we 20 
collected data from the right leg for 2 minutes and then from the left leg for 2 minutes. Infants 21 
were picked up and held by their parent between trials.   22 
 For infants with MMC, we recorded aspects of the infant’s medical history including lesion 23 
 7 
level, surgeries and musculoskeletal conditions. We noted if one leg was more affected than the 1 
other. If the legs were equally affected, and for infants with TD, we assigned the right leg as less 2 
affected for statistical analysis. For all infants, we took anthropometric measurements including 3 
body length, weight, greater trochanter to lateral malleolus length, thigh length, foot length, thigh 4 
circumference and leg circumference. We assessed concurrent motor skill development level by 5 
administering the motor items from the Bayley Scales of Infant Development II 7. We recorded 6 
the date of administration and whether the infant was able to perform the skill on this day. 7 
Data Analysis 8 
 Study 1 data were collected directly in the Vicon Peak Motus software program. Study 2 9 
data were transferred from the digital cameras into the software and synchronized. We then 10 
digitized hip, knee and foot markers for each trial. We were able to successfully identify the 11 
markers for the first 6147 frames of every trial, corresponding to the first 102.5 seconds of data 12 
from each 120-s, 60 Hz recording session. Using the same number of data points for every trial is 13 
important for calculating ApEn, so longer trials were shortened to provide a consistent amount of 14 
data for every trial. We calculated hip segmental angles as the angle between the thigh segment 15 
and the surface on which the infants rested. The angle data were then filtered with a 6 Hz 16 
Butterworth filter and exported for further analyses. 17 
 Before we could use the nonlinear tool ApEn to assess the complexity of infants’ 18 
spontaneous movement data we first had to test the hip angle data for a deterministic structure 19 
(mathematically defined as non-random). We used Chaos Data Analyzer (CDA) software 20 
Professional Version23 to create randomly shuffled surrogate datasets for all hip angle time 21 
series24,25. Subsequently, we computed the largest Lyapunov Exponent values for all surrogate 22 
and original time series and compared them. Significant differences were found between the 23 
 8 
surrogate and original Lyapunov Exponent values, indicating that the original hip angle data 1 
were not random, but deterministic. 2 
 Next we used MATLab programs to determine the parameters necessary for ApEn 3 
calculations (m = 2 and r = 0.2) and then to calculate ApEn. Note that determining parameters m 4 
and r involve numerous calculations more detailed than elaborated here. For in-depth description 5 
of the process, readers are directed to Stergiou et al., 200425. To calculate quantity of 6 
movements, we tested our data to find a threshold for movement identification that was 7 
consistent with our observations of spontaneous movements during frame-by-frame video 8 
analysis. We wanted to define a threshold that was much more sensitive to small movements 9 
than a trained observer could see, while still consistent with observed amounts of movement. We 10 
defined a movement as more than 2 degrees of hip flexion or extension in the sagittal plane in 11 
167 ms, and counted the number of times this threshold was exceeded per trial. A lower number 12 
for the quantity of movement value indicates fewer and/or shorter movements. 13 
Statistics 14 
We used a 2 (group: MMC or TD) x 2 (leg: more or less affected) x 4 (age: 1, 3, 6 or 9 15 
months) linear mixed model to test for main effects and interactions. Dependent variables were 16 
ApEn values in the first test and quantity of movement in the second. Group, leg and age were 17 
treated as fixed effects with participant as a repeated measure (by age and leg) with a diagonal 18 
structure. To look at relationships between ApEn values, motor development and factors 19 
affecting motor development in infants with MMC, we tested for Pearson correlations between 20 
ApEn values and lesion level (high = L1, L2, medium = L2/L3, L3, L4, or low = L4/L5, L5, S1), 21 
ponderal index and age at which we observed the infant demonstrate selected items of the Bayley 22 
scale (as shown in Table 3). We chose five items to represent major milestones across the age 23 
 9 
range of our study: sits alone momentarily, sits alone 30 seconds or more, pulls to standing 1 
position, walks with minimal help and walks alone, 3 steps or more. We used a two-tailed 2 
Pearson correlation to determine if ApEn values were significantly correlated with the selected 3 
variables in infants with MMC. For the significantly correlated milestones, we used a one-tailed 4 
correlation to follow up and test whether ApEn values at 1, 3, 6 or 9 months of age were 5 
significantly correlated with the age at which we observed achievement of the selected 6 
milestone. We did not test for correlations in infants with TD because we only had complete 7 
Bayley items for 14/30 infants with TD as we did not follow the infants with TD in Study 2 after 8 
their 9-month visit to find out when they started walking independently. We used Predictive 9 
Analytics Software (SPSS: An IBM Company, Chicago, IL) version 18 for statistical analysis 10 
and set our alpha level of significance at 0.05. 11 
RESULTS 12 
ApEn Values 13 
For the ApEn linear mixed model, we obtained a significant group effect (F[1,80]= 6.40, 14 
p = 0.01). There was not a significant leg effect or age effect. There were no significant 15 
interactions. As shown in Figure 1, infants with MMC demonstrated lower ApEn values than 16 
infants with TD. 17 
Quantity of Movement 18 
 19 
For the quantity of movement linear mixed model, we obtained a significant group effect 20 
(F[1,89]= 24.95, p < 0.01) and age effect (F[3,44]= 5.73, p < 0.01). There was not a significant 21 
leg effect or any significant interactions. As demonstrated in Figure 2, the significant group 22 
effect was due to infants with MMC producing fewer movements than infants with TD. For the 23 
significant age effect, infants produced fewer movements as they got older. Follow-up analysis 24 
 10 
revealed that infants produced fewer movements at 6 and 9 months of age as compared to 1 1 
month of age (p’s < 0.05). 2 
Correlations 3 
 For infants with MMC, there was a significant two-tailed negative correlation between 4 
ApEn values and the age at which we observed walking alone, 3 steps or more (-0.48, p = 0.02). 5 
We followed up with one-tailed correlations between the age at which we observed walking 6 
alone, 3 steps or more, and ApEn values at 1 month (NS), 3 months (-0.82, p = 0.02), 6 months (-7 
0.86, p = 0.01) and 9 months (-0.79, p = 0.03). Lower ApEn values for infants with MMC at 3, 6 8 
and 9 months of age were significantly correlated with later age of walking alone, 3 independent 9 
steps. There was also a significant one-tailed negative correlation between ApEn values and 10 
lesion level, higher lesion levels were correlated with lower ApEn values (-0.30, p = 0.02). 11 
Correlations between ApEn values and other motor milestones or ponderal index were not 12 
significant. 13 
DISCUSSION 14 
The infants with MMC in our study demonstrated lower overall ApEn values than infants 15 
with TD from primarily cross-sectional measurements at 1, 3, 6 and 9 months of age. Lower 16 
ApEn values for infants with MMC represent less complex and thus less organized lower 17 
extremity movements as compared to their peers with TD. Less organized movements have also 18 
been observed in the spontaneous upper extremity movements of infants with brain injury 26 and 19 
postural control in infants born preterm 27. Less organized movements reflect impaired 20 
neuromotor control of movement and ApEn values are a sensitive tool for therapists and 21 
researchers to use to quantify neuromotor control of movement and show improvement as a 22 
result of intervention. 23 
 11 
Although the patterns of results for quantity of movement and ApEn values show similar 1 
trajectories, ApEn measures aspects of movement beyond mere quantity. This is demonstrated in 2 
the 3-month data points, where the group difference in ApEn values (Figure 1) is smaller than 3 
the group difference in quantity of movement (Figure 2). If ApEn values were purely reflective 4 
of quantity of movement, we would expect to see identical trajectories for ApEn and quantity of 5 
movement. Future studies are necessary to see if ApEn measures are more sensitive than current 6 
measures to changes in neuromotor control of spontaneous lower extremity movements with 7 
intervention, however previous research suggests it might be 27,28. 8 
Beyond quantity of movement, ApEn values reflect the regularity and repeatability of the 9 
movement patterns exploring how similar different time points are during the movement, 10 
providing a measure of overall complexity. ApEn values exist on a continuum of 0 to 2. An 11 
ApEn value of 0 represents complete regularity of a pattern and is a low complexity state. An 12 
ApEn value of 2 represents complete irregularity of a pattern and is also a low complexity state. 13 
A high complexity state is somewhere in the middle of the range. Our results showed ApEn 14 
mean values for all infants ranging from approximately 0.13 to 0.25, indicating that spontaneous 15 
leg movements were closer to the regular pattern end of the continuum compared to other types 16 
of movement, which makes sense based on the inherent oscillatory nature of leg movements. 17 
Studies of supine and sitting postural control in infants found ApEn values of around 1 and 0.23-18 
0.63, respectively, more in the middle of the continuum27,28. Additionally, infants with MMC in 19 
our study produced leg movements with lower ApEn values than their peers with TD, indicating 20 
more regularity and less complexity across their kicking movements, consistent with impaired 21 
neuromotor control.  22 
 12 
An important point to consider is that both groups have higher ApEn values at one month 1 
than at nine months. In general ApEn values are decreasing with age, indicating more regularity 2 
and less complexity in kicking movements across time. One could take the values out of context 3 
and interpret that MMC one-month ApEn values being approximately equal to TD nine-month 4 
values means infants with MMC are “better” than infants with TD and reach the goal of lower 5 
ApEn values faster. This interpretation would not be correct, however, as it overlooks the fact 6 
that kicking movements change across time, infants at one month of age do not move their legs 7 
like infants at nine months of age. As control develops, infants with TD are able to hold their 8 
upper leg stable and move only their lower leg 29. It follows that by moving only one segment, 9 
instead of two, movements would become more regular and less complex, leading to lower ApEn 10 
values. Additionally, thinking of the emergence through time of more alternating kicks and 11 
eventual walking, it also fits that spontaneous leg movements would become more regular and 12 
less complex as infants strengthen their patterns of alternating leg movements. Lower ApEn 13 
values within age groups for infants with MMC at 3, 6 and 9 months of age, however, were 14 
significantly correlated with later age of walking alone, 3 independent steps. This indicates a 15 
likely interaction with lesion level, as lower ApEn values were correlated with higher lesion 16 
levels. These results imply that neuromotor control of leg movements in infants with MMC is 17 
fundamentally different than in infants with TD; we need to design further studies to specifically 18 
investigate and understand the factors affecting developmental trajectories in infants with MMC.  19 
ApEn values must always be interpreted in context; for spontaneous leg movements 20 
infants with TD show a pattern of decreasing values across time as neuromotor control develops 21 
and movement patterns change. Although lower ApEn values appear ideal for infants with TD, 22 
this does not appear to be the case for infants with MMC. Infants with MMC start off with lower 23 
 13 
ApEn values as compared to their peers with TD and decrease further over time, and those with 1 
the lowest values achieve independent walking later. ApEn values for infants with MMC are 2 
following the same trajectory as infants with TD, however they have consistently lower ApEn 3 
values than their peers with TD at comparable ages. This difference is important as it reflects a 4 
unique characteristic of dynamic control between groups in neuromotor control and/or 5 
movement patterns of spontaneous leg movements at comparable age and experience levels.  6 
Currently, although they may be evaluated before discharge from the hospital following 7 
birth, physical therapy intervention to address impaired neuromotor control for infants with 8 
MMC is typically initiated around 3, 6 or even 9 months of age 6 (see Table 2). This is in contrast 9 
to adults with spinal cord injury, for whom therapists, researchers and third-party payers 10 
recognize the importance of aggressive early intervention to promote positive neural plasticity 11 
changes and recovery of function. Adults with spinal cord injury start physical therapy as soon as 12 
possible, with aggressive therapy initiated when they are medically stable, within days or weeks 13 
of their injury. Infants with MMC, however, are approximately 11-17 months post lesion when 14 
therapy is initiated. This approach accepts a loss of plasticity and does not promote the 15 
development of optimal neuromotor control. 16 
What happens across the first months of life, before therapy is typically initiated, is of 17 
crucial importance to the development of optimal neuromotor control. Although infants with 18 
MMC demonstrate the same quantity of spontaneous kicking movements before and at birth, 19 
they demonstrate less movement from one month of age on as compared to infants with TD 20 
6,15,30-32. Lower quantity of movement relates to less organized movement through less repetitions 21 
of the perception-action cycle. A lower number of movements provide diminished opportunities 22 
to develop coordinated movements and neural networks that support stable leg movement 23 
 14 
patterns 33. Infants with MMC do respond adaptively to external constraints by increasing or 1 
decreasing quantity of kicking 15, demonstrating that their lower quantity of movements is 2 
amenable to intervention. We propose that increasing the quantity of lower extremity movements 3 
and cycles of perception-action from birth on should lead to optimal neuromotor control of the 4 
legs, and that this will be reflected in higher ApEn values in infants with MMC indicating more 5 
organized movements and better clinical outcomes.  6 
It could be argued that lesser movement quantity alone is a sufficient, easier to obtain 7 
measure of neuromotor delay in infants with MMC. Barriers to using movement quantity as a 8 
clinical assessment, however, include standardizing the definition of a movement, introducing 9 
observer-related variability and addressing the natural variability in infant performance. For 10 
these reasons, it would be very difficult for an observer to use a stopwatch and get reliable 11 
measurements of quantity of spontaneous leg movements. One could use cameras and software 12 
analysis, as we do in the laboratory. While this increases the reliability of the assessment it 13 
makes it much less “clinic friendly”.  ApEn, alternatively, can measure the regularity and 14 
complexity of movement patterns as long as some minimal amount of leg movement is recorded. 15 
Repeated measurements could theoretically be used to assess changes in the regularity and 16 
complexity of spontaneous kicking patterns across time, independent of the fact that an infant 17 
kicked more or less at a given session. We did not, however, test the inherent variability of 18 
repeated measurements in this study. 19 
In summary, we have shown here that ApEn reflects impaired neuromotor control and 20 
less organized, less complex movements of the lower extremities of infants with MMC as 21 
compared to infants with TD starting at one month of age. Our study begins to demonstrate the 22 
feasibility of ApEn as a valuable tool for identifying and quantifying impaired neuromotor 23 
 15 
control in infants with MMC. ApEn assessment adds unique information to current clinical 1 
assessments and supports the need for therapeutic intervention early in life.  2 
 3 
STUDY LIMITATIONS 4 
 5 
 The major limitation of our study is that it is not a longitudinal design. Additionally, we 6 
report only lesion level of surgical repair, which is not as meaningful for behavior as a functional 7 
neurological level. We only tested infants once at each time point, and infant behavior is 8 
inherently variable. It would be ideal to test infants twice at each age and follow them from birth 9 
through independent walking, and we plan to pursue such a study. Such a design would allow us 10 
to test the inherent variability of ApEn measurements as well as rigorously test the relationship 11 
between ApEn, factors affecting motor development and outcomes in infants with MMC. This 12 
study, however, provides necessary background information on the feasibility and usefulness of 13 
ApEn as an outcome measure before recruiting infants and their families for a study design that 14 
would be much more demanding of their time. We also appreciate the need for software 15 
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FIGURE LEGENDS 1 
 2 
Figure 1. Mean Approximate Entropy values for each group by age. Error bars represent 3 
standard error of the mean. The overall group main effect is significant. TD = typical 4 
development, MMC = myelomeningocele.   5 
 6 
Figure 2. Mean quantity of movement (defined as greater than 2 degrees of hip flexion or 7 
extension in 167 ms) per 6147 frames per trial for each group by age. A lower value indicates 8 
fewer and/or shorter movements. Error bars are the standard error of the mean. The overall group 9 
and age main effects are significant. TD = typical development, MMC = myelomeningocele.    10 
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